May 01, 2025

Who Stops GA Therapy—and Why

A large, retrospective analysis of more than 20,000 eyes treated for geographic atrophy (GA) suggests that several baseline clinical characteristics—including coexisting neovascular age-related macular degeneration (nAMD) and poor initial visual acuity—are significantly associated with early discontinuation of intravitreal complement inhibitor therapy.

Retinal Physician